论文部分内容阅读
目的了解肝病治疗仪联合脂肪碎解方治疗慢性肝病的效果。方法选取医院门诊病例90例,随机分为肝病治疗仪治疗组和对照组各45例。所有参选样本经甲乙丙丁或肝筛查,肝功能生化检查,抗核抗谱全套检查,血脂、肝胆脾肾彩超,饮酒史及量、既往史、家族史。治疗组采用肝病治疗仪联合脂肪碎解方中药辨证施治,对照组只用西药保肝降酶治疗,连续半年,对比观察肝功能指标。结果治疗组ALP、r-GT、AST、TBA、TBLL的降低率分别为47.9%、47.31%、44.04%、64.44%、56.45%,对照组为14.70%、33.69%、25.00%、39.24%、53.32%,治疗组明显优于对照组(P<0.05)。结论肝病治疗仪联合脂肪碎解方治疗慢性肝病疗效可靠,方便实用。
Objective To understand the effect of liver disease treatment instrument combined with fat crushing treatment of chronic liver disease. Methods 90 hospital outpatient cases were selected and randomly divided into liver disease treatment instrument treatment group and control group of 45 cases. All participating samples were tested by Ethacrimopamine or liver, biochemical examination of liver function, complete examination of anti-nuclear anti-nuclear spectrum, blood lipid, liver and gallbladder spleen and kidney ultrasound, alcohol consumption history and quantity, past history and family history. The treatment group was treated with liver disease treatment instrument combined with the treatment of traditional Chinese medicine syndrome differentiation, the control group only with Western medicine liver protection and enzyme treatment, continuous six months, the comparison of liver function indicators. Results The reduction rates of ALP, r-GT, AST, TBA and TBLL in the treatment group were 47.9%, 47.31%, 44.04%, 64.44% and 56.45% respectively, while those in the control group were 14.70%, 33.69%, 25.00%, 39.24% and 53.32 %, The treatment group was significantly better than the control group (P <0.05). Conclusion Liver disease treatment instrument combined with fat crushing prescription for the treatment of chronic liver disease is reliable, convenient and practical.